» Articles » PMID: 24852301

PROSPECTIV-a Pilot Trial of a Nurse-led Psychoeducational Intervention Delivered in Primary Care to Prostate Cancer Survivors: Study Protocol for a Randomised Controlled Trial

Abstract

Background: Prostate cancer survivors can experience physical, sexual, psychological and emotional problems, and there is evidence that current follow-up practices fail to meet these men's needs. Studies show that secondary and primary care physicians see a greater role for primary care in delivering follow-up, and that primary care-led follow-up is acceptable to men with prostate cancer.

Methods And Analysis: A two-phase study with target population being men who are 9-24 months from diagnosis. Phase 1 questionnaire aims to recruit 300 men and measure prostate-related quality of life and unmet needs. Men experiencing problems with urinary, bowel, sexual or hormonal function will be eligible for phase 2, a pilot trial of a primary care nurse-led psychoeducational intervention. Consenting eligible participants will be randomised either to intervention plus usual care, or usual care alone (40 men in each arm). The intervention, based on a self-management approach, underpinned by Bandura's Social Cognitive Theory, will provide advice and support tailored to these men's needs and address any problems they are experiencing. Telephone follow-up will take place at 6 months. Study outcomes will be measured by a questionnaire at 7 months. Phase 1 will allow us to estimate the prevalence of urinary, sexual, bowel and hormone-related problems in prostate cancer survivors and the level of unmet needs. 'Usual care' will also be documented. Phase 2 will provide information on recruitment and retention, acceptability of the intervention/outcome measures, effect sizes of the intervention and cost-effectiveness data, which is required to inform development of a larger, phase 3 randomised controlled trial. The main outcome of interest is change in prostate-cancer-related quality of life. Methodological issues will also be addressed.

Ethics And Dissemination: Ethics approval has been gained (Oxford REC A 12/SC/0500). Findings will be disseminated in peer-reviewed journals, at conferences, through user networks and relevant clinical groups.

Trial Registration Number: ISRCTN 97242511.

Citing Articles

Living With and Beyond Cancer With Comorbid Conditions: Qualitative Insights to Understand Psychosocial Support Needs.

Cavers D, Cunningham-Burley S, Watson E, Banks E, Campbell C Health Expect. 2024; 27(5):e70039.

PMID: 39369340 PMC: 11456226. DOI: 10.1111/hex.70039.


Educational Needs in Oncology Nursing: A Scoping Review.

Solera-Gomez S, Benedito-Monleon A, LLinares-Insa L, Sancho-Cantus D, Navarro-Illana E Healthcare (Basel). 2022; 10(12).

PMID: 36554019 PMC: 9778242. DOI: 10.3390/healthcare10122494.


Follow-up strategies following completion of primary cancer treatment in adult cancer survivors.

L Hoeg B, Bidstrup P, Karlsen R, Friberg A, Albieri V, Dalton S Cochrane Database Syst Rev. 2019; 2019(11).

PMID: 31750936 PMC: 6870787. DOI: 10.1002/14651858.CD012425.pub2.


Living with and beyond cancer with comorbid illness: a qualitative systematic review and evidence synthesis.

Cavers D, Habets L, Cunningham-Burley S, Watson E, Banks E, Campbell C J Cancer Surviv. 2019; 13(1):148-159.

PMID: 30685822 PMC: 6394454. DOI: 10.1007/s11764-019-0734-z.


Follow-up care after treatment for prostate cancer: protocol for an evaluation of a nurse-led supported self-management and remote surveillance programme.

Frankland J, Brodie H, Cooke D, Foster C, Foster R, Gage H BMC Cancer. 2017; 17(1):656.

PMID: 28927389 PMC: 5606080. DOI: 10.1186/s12885-017-3643-4.


References
1.
Smith D, King M, Egger S, Berry M, Stricker P, Cozzi P . Quality of life three years after diagnosis of localised prostate cancer: population based cohort study. BMJ. 2009; 339:b4817. PMC: 2784818. DOI: 10.1136/bmj.b4817. View

2.
Loprinzi C, Dueck A, Khoyratty B, Barton D, Jafar S, Rowland Jr K . A phase III randomized, double-blind, placebo-controlled trial of gabapentin in the management of hot flashes in men (N00CB). Ann Oncol. 2009; 20(3):542-9. PMC: 2733071. DOI: 10.1093/annonc/mdn644. View

3.
Boberg E, Gustafson D, Hawkins R, Offord K, Koch C, Wen K . Assessing the unmet information, support and care delivery needs of men with prostate cancer. Patient Educ Couns. 2003; 49(3):233-42. DOI: 10.1016/s0738-3991(02)00183-0. View

4.
Sanda M, Dunn R, Michalski J, Sandler H, Northouse L, Hembroff L . Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med. 2008; 358(12):1250-61. DOI: 10.1056/NEJMoa074311. View

5.
Szymanski K, Wei J, Dunn R, Sanda M . Development and validation of an abbreviated version of the expanded prostate cancer index composite instrument for measuring health-related quality of life among prostate cancer survivors. Urology. 2010; 76(5):1245-50. PMC: 3152317. DOI: 10.1016/j.urology.2010.01.027. View